饮食和益生菌干预对代谢综合征和阻塞性睡眠呼吸暂停患者的影响
Amina Venter1, Amin-Florin El-Kharoubi2, Mousa El-Kharoubi3
1Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.
Clinics and practice
|September 26, 2025
概括
饮食干预和益生菌显著改善了代谢综合征和阻塞性睡眠呼吸暂停患者的代谢和神经化学标志物. 个性化的饮食计划与益生菌相结合,为精确的生活方式医学提供了一个有希望的方法.
科学领域:
- 代谢综合征和睡眠呼吸暂停研究
- 营养神经科学 营养神经科学
- 微生物组与健康
背景情况:
- 代谢综合征 (MS) 和阻塞性睡眠呼吸暂停 (OSA) 经常同时发生,使炎症和代谢功能障碍恶化.
- 了解MS,OSA和神经化学失衡之间的相互作用对于有效治疗至关重要.
- 这项研究调查了生活方式干预对这些复杂疾病的影响.
研究的目的:
- 评估饮食治疗和饮食-益生菌联合治疗对MS和OSA患者的代谢,血液动力学和神经化学参数的影响.
- 具体评估神经递质GABA和谷氨酸的变化.
- 通过集群分析识别患者对干预措施的不同反应模式.
主要方法:
- 一项前性随机研究,涉及120名患有并存MS和OSA的患者.
- 参与者被分配到对照组,饮食治疗或饮食治疗加益生菌组六个月.
- 关键的结局指标包括BMI,内脏脂肪,脂质谱,氧和和尿中的GABA/谷氨酸水平,用K-means集群和PCA.分析.
主要成果:
- 饮食治疗显著降低了BMI,内脏脂肪,甘油三,尿酸和CRP.
- 综合饮食和益生菌组显示,内脏脂肪的减少增加,谷氨酸和GABA水平显著改善.
- 氧和在所有组都得到改善,在益生菌组中观察到的最实质性的增加.
结论:
- 个性化的饮食干预措施,特别是当添加益生菌时,有效地提高了MS和OSA患者的代谢,炎症和神经化学特征.
- 聚类算法可以将患者分为不同的响应表型,为精确的生活方式医学铺平道路.
- 需要进一步的研究来探索长期影响和优化针对微生物群的策略.
相关概念视频
Sleep Apnea
481
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
481
Management of Insomnia
542
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
542
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
247
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
247
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Insufficient Sleep and Sleep Deprivation
838
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
838
COPD: Management Using Bronchodilators and Corticosteroids
734
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
734


